Abstract
In the increasing demand for virus vaccines, large-scale production of safe, efficient, and economical viral antigens has become a significant challenge. High-cell-density manufacturing processes are the most commonly used to produce vaccine antigens and protein drugs. However, the cellular stress response in large-scale cell culture may directly affect host cell growth and metabolism, reducing antigen production and increasing production costs. This study provided a novel strategy of the antioxidant auxiliary system (AAS) to supply molecular hydrogen (H2) into the cell culture media via proton exchange membrane (PEM) electrolysis. Integrated with a high-density cell bioreactor, the AAS aims to alleviate cellular stress response and increase viral vaccine production. In the results, the AAS stably maintained H2 concentration in media even in the high-air exposure tiding cell bioreactor. H2 treatment was shown safe to cell culture and effectively alleviated oxidative stress. In two established virus cultures models, bovine epidemic fever virus (BEFV) and porcine circovirus virus type 2 (PCV-2), were employed to verify the efficacy of AAS. The virus yield was increased by 3.7 and 2.5 folds in BEFV and PCV-2 respectively. In conclusion, the AAS-connected bioreactor effectively alleviated cellular oxidative stress and enhanced virus production in high-density cell culture.
Similar content being viewed by others
Introduction
Bioreactors play an important role in producing large-scale vaccines in cell culture, which can provide more efficient and cost-effective vaccine production. Large-scale and high-density conditions in bioreactors may cause cellular stress response and then decrease viral production1,2,3. Many cellular stress responses, such as cellular oxidative stress, ER stress, and senescence-like response, could inhibit or decrease virus amplification in the cell culture system. In previous research, the cellular oxidative response has been reported to decrease Chinese Hamster Ovary (CHO) cell-producing protein drugs4,5. In our previous study, the stress-induced senescence-like response also inhibited BEFV virus replication in the BHK-21 cells6. Thus, how to resolve cellular stress response in high-density cultivation still was a formidable challenge in bioreactors.
Oxidative stress refers to an imbalance between free radical production and intracellular antioxidant responses in a cell7,8,9. When reactive oxygen species (ROS) are excessively produced, they may trigger lipid peroxidation, protein denaturation, and nucleic acid damage. Therefore, oxidative stress causes severe damage to cells in vivo and in vitro environments10,11. ROS production can trigger the host cells' antiviral inflammatory response in viral infections12. Consequently, regulating ROS levels to maintain cellular homeostasis in a bioreactor was very important to the biopharmaceutical industry. The cellular oxidative stress in the manufacturing process may arise in conditions including uneven oxygen distribution, high cell density, lack of nutrients, waste accumulation, and virus infection. The common methods of eliminating ROS production are reducing mechanical damage or directly adding antioxidant chemical reagents in the bioreactor, such as vitamin C, vitamin E, and glutathione13,14. However, direct additional chemical antioxidants in the culture media not only require further isolation process and monitoring residuals but also difficult to quickly adjust their amounts with the manufacturing process. Here, a new strategy by using H2 as the antioxidant material to reduce oxidative stress response quickly, easily, and with no residuals in the production process.
H2 is a novel antioxidant material to efficiently reduces oxidative stress15,16. The water molecules dissociate weakly, splitting into H+ and OH− ions. Through electrolysis, under the influence of electron reception at the cathode, hydrogen ions transform into H2 highly efficiently. The biological activity of H2 and hydrogen-rich water has been extensively studied in humans, animal models, and cell cultures. Many previous studies reported that H2 can quickly reduce the oxidants in human fibroblast cells induced by irradiation damage17,18,19.
Here, we designed an antioxidant device, the antioxidative auxiliary system (AAS), to directly generate H2 within cell culture media in a high-density bioreactor. The results showed that the AAS supplied H2 into the cell culture medium to stabilize cellular oxidative stress and increase virus yields in the bioreactor. Two virus culturing models, BEFV in BHK-21 cells and PCV-2 in PK-15 cells were employed. In the virus production processes, the AAS device effectively reduced oxidative stress and increased virus yields by 2 to 4 folds. The present research is the first to apply H2 for viral vaccine production.
Results
Device design for AAS connected with BelloCell-500AP lab-scale bioreactor
The AAS system included a power-controlling unit and a PEM electrolysis core. The power control unit was constructed with a microcontroller, power supply, and timer-connected power, which was used to achieve different requirements such as current, voltage, and activation times. The PEM electrolysis core is centered around connecting the BelloCell-500AP system (cathode), a pure water system (anode), and pumping by two peristaltic pumps (Fig. 1). H2 was electrolyzed directly into the culture media by the PEM electrolysis core in the cathode, and the O2 was generated in the anode in pure water. In the cathodic region of water electrolysis, the reduction of water molecules generates hydroxide ions (OH−), resulting in an alkaline environment of the culture media flowing through the cathode and could be used to balance the cell-secreted acid during growth. A 0.22 µm filter was provided to the pure water system to vent the O2 gas out. In the BelloCell-500AP lab-scale bioreactor, H2 will gradually dissipate through the BelloCell-500AP air venting filter. Thus, the power control system was needed to regulate proper activation times and maintain H2 concentration in the culture environment. The advantage of this design is that it could be adjusted for various experimental parameters, including the activation frequency of the electrolysis core, voltage, current, and the flow rate of the supplementary buffer.
First, the device was tested by using different current values (0.05 A, 0.1 A, 0.2 A, 0.3 A, 0.4 A, 0.5 A, 2 A) with 15-min activation and 15-min deactivation intervals in MEM medium without cells for the H2 generation estimation. The results demonstrated that H2 concentrations could achieve 0.6–0.8 ppm within 25 min in a 500 ml culture medium by a current of more than 0.2 A, and could achieve 1 ppm with a current of 2 A (Fig. 2A). However, with the increase in current and time, the pH value of the MEM medium increased rapidly (Fig. 2B). However, since high pH will hurt cells, the current must be regulated carefully.
Actually, using a high current, 2 A, can achieve higher hydrogen concentrations, but excessive pH and bubble formation during the electrolysis process will be harmful to the cells. A constant 0.5 A condition was employed for all experiments to make 0.6 ~ 0.8 ppm in the lab-scale BelloCell-500AP bioreactor. The H2 concentration and pH within the bioreactor can be regulated quickly. This feature allows AAS to be adjusted for different bioreactors easily.
The AAS showed no cytotoxicity and reduced cellular oxidative stress in the BelloCell-500AP
To confirm whether the cells showed cytotoxicity or growth inhibition by using the AAS-linked bioreactor, the cell number and glucose-consuming rate were employed as indicators. After BHK-21 cells were inoculated on Day 0, the matrix from the AAS-linked or the control bioreactor was sampled for cell number calculation every day from Day 1 to Day 8. A fed-batch method was employed in this experiment. The growth media was exchanged only once on day 2. From day 3 to day 8, glucose was exclusively supplied at a final concentration of 100 mg/dl in the existing growth media. The cell populations reached maximum growth on day 4, followed by a period of decreasing cell numbers due to the sole supply of glucose. On day 8, the final day, only a sparse population of cells remained in the bioreactor. This process facilitated the establishment of conditions characterized by cell growth increment and starvation decrement within a single culture period, allowing for easy comparison of the two growth conditions. In Fig. 3A, cell growth curve results, both the H2-treated and H2-free groups reached the peak of cell counts on day 4, with values of 2.0 x 109 cells/bt and 1.9 x 109 cells/bt, respectively. The cell number started to shrink after day 4 both in H2-treated or H2-free groups. The results indicated that AAS-generated H2 treatment did not cause cytotoxic effects in growing and stressing conditions. The glucose consumption rate also showed similar results, the H2-treated group did not significantly decrease cellular glucose metabolism. Furthermore, the pH remained consistently within the range of 7.4 to 7.6 during the entire culture period, this indicates that the PEM electrolyzed will not cause pH quick raising in this experiment condition (Fig. 3B). The dissolved hydrogen concentration is analyzed to evaluate the H2-supplying efficiency of the AAS when connecting BelloCell-500AP. The results showed that hydrogen concentration in the bioreactor could be maintained between 0.6-0.8 ppm stably in the conditions of AAS 15 minutes start, 15 minutes stop, and 0.5 A current (Fig. 3C).
In order to verify the antioxidant efficacy of the AAS system in high-density cell culture, BHK-21 cells were inoculated into BelloCell-500AP and cultured as described in the previous section. The cells were trypsinized from the matrix on day 4, day 5, and day 6 for the ROS generation assay. After day 4, the cells faced starvation-stressing conditions without growth media exchange. In the ROS assay, the cellular oxidative stress was induced by H2O2 as the indicated concentration followed by flow cytometry analysis to evaluate the ROS tolerance response in the cells treated by AAS-generated H2 and in the H2-free control group.
The results showed that the cellular ROS levels increased along with the culture time, but the ROS levels in H2-treated cells were significantly lower than in the H2-free group (Fig. 4A). The difference between H2-treated and H2-free groups more clear in 4 µM, 10 µM, and 20 µM H2O2 induction (Fig. 4B–D). In conclusion, the AAS could effectively alleviate cellular oxidative stress in the high-density cell bioreactor.
The AAS-connected BelloCell-500AP improves BEFV production in BHK-21 cells
The BEFV virus replicates in BHK-21 cells rapidly and causes obvious cytopathic effects (CPE) within 48 h. Here, the BEFV model was used to estimate the effects of the AAS-connected bioreactor for quick virus growth in high-density cell conditions. The experimental process is shown in Fig. 5A. BHK-21 cells were inoculated into two BelloCell-500AP bottles at 4.6 × 108 cells/bt, and the cell number reached 1.5 and 1.8 × 109 cells/bt on day 3, then were inoculated with BEFV, and the virus titer from 24 to 96 h post-infection (h.p.i) were analyzed. The AAS was turned on 24 h before virus inoculation in the H2-treated group (from day 2 to day 7).
The results showed that the cells were consumed by the virus very quickly in H2-treated groups at 24- and 48-h.p.i. The virus titer in the H2-treated group increased faster than in the H2-free group (Fig. 5B brown arrows). After 48 h.p.i, only rare cell residual in the bioreactor, and the virus titer shows low at 96 h.p.i. The total amount of virus antigens in the harvest bulks at 48 and 96 h.p.i are shown in Fig. 5C. The total virus harvest in H2-treated group was significantly higher than in H2-free control group at 48 h.p.i. The fold change of H2-treated over H2-free groups at 48 and 96 h.p.i are 3.96 and 0.87 as indicated (Supplementary Fig. S1). Since the BEFV usually causes the CPE close to 72 h.p.i, the virus titer in the H2-free group showed a quick rise at 72 h.p.i (Fig. 5B day 6), like the general condition. However, the total amount of virus yield harvested in the H2-treated group was significantly higher than the H2-free group (3.7-fold) (Supplementary Table 1). In this virus culture experiment, the AAS can stably supply dissolved H2 as 0.6–0.8 ppm during virus infection (Fig. 5D).
The AAS-connected BelloCell-500AP improves PCV-2 production in PK-15 cells
In PCV-2 production tests, the PCV-2 infects PK-15 cells in low-density conditions (1.04 × 108 cells/bt) at the beginning and the virus replication rate is slow. This lets us harvest the virus antigen several times in one bioreactor. The experimental process is demonstrated in Fig. 6A, the AAS was turned on at 96 h.p.i to minimize the cellular stress response induced by the following high cell density and virus replication condition.
Before activating AAS, the PK-15 cell numbers reached 7.6 × 108 cells/bt and 8.5 × 108 cells/bt in the H2-treated group and H2-free group on 96 h.p.i, respectively. Subsequently, the PK-15 cells decreased quickly during 96 ~ 144 h.p.i, especially in the H2-treated group. In this period, the virus titer in the H2-treated group increased more rapidly than in the H2-free group. Between 144 ~ 216 h.p.i, cell numbers in both groups gradually recovered, with the H2-treated group exhibiting faster growth, and the virus titer being higher than in the H2-free group (Fig. 6B). This virus growth may have resulted from the PCV2 genomic DNA being dependent on cell host replication. The culture medium was exchanged at 96 h.p.i (day 6) and 168 h.p.i (day 9). Consequently, cell growth was observed on days 7 and 10. The cell death peak and lower cell numbers were observed on day 8. Similarly, the virus supernatant was harvested on day 9 by replacing fresh culture media, resulting in a lower virus titer on day 10. Notably, the PCV2 virus titer may not exhibit a 100% correlation with cell death. We observed at least two waves of PCV-2 replications, with the first wave occurring at 144 h.p.i (Fig. 6B, brown arrow) and the second wave extending beyond 216 h.p.i. In Fig. 6B, the results show the dynamic changes in cell number and virus titer in the cell bioreactor.
The amount of virus antigens in the harvest bulks at 96, 168, and 216 h.p.i are shown in Fig. 6C. Before turning on AAS (at 96 h.p.i), the amounts of virus yield in the two groups were similar, but the virus in the H2-tread group was significantly higher than in the H2-free control group after AAS linked in (168 and 216 h.p.i) (Fig. 6C). The H2-treated process enhanced virus production 4.3-fold at 168 h.p.i and 3.2-fold at 216 h.p.i (Supplementary Fig. S1). The total amount of virus yield harvested in the H2-treated group was significantly higher than the H2-free group (2.5-fold) (Supplementary Table 1) In this virus culture experiment, the AAS can stably supply dissolved H2 as 0.6–0.8 ppm during virus infection (Fig. 6D).
The AAS alleviated the cellular oxidative stress during virus infection
In order to confirm the antioxidant effect of AAS in the viral infected cells. The cellular oxidative condition was analyzed at 24 h after virus inoculation in BEFV and PCV-2 infection models. The results showed that the virus-induced cellular oxidative stress response was alleviated by using AAS-generated H2 treatment in both BEFV (Fig. 7A) and PCV-2 (Fig. 7B). As the higher concentration of H2O2 induction was used, 10 µM and 20 µM in BEFV and 80 µM in PCV-2, the antioxidant phenomenon became significant.
Discussion
Maintaining homeostasis in the cell cultured within a high-density bioreactor is a crucial aspect of the biomanufacturing process. Previous research has mentioned that alleviated oxidative stress in bioreactors is advantageous for high-yield virus and recombinant protein production20,21. Furthermore, our prior studies also found that stress-induced cellular senescence-like response may inhibit BEFV virus production6. How to alleviate the cellular response is important in the pharmaceutical industry when using cell bioreactors. In the present study, the virus production was significantly accelerated by using AAS to alleviate ROS-induced cellular stress response during virus infection.
Cellular stress responses in generally inhibit virus growth and replication through various factors, such as cell inflammation, oxidative stress, cell cycle arrest, and cellular senescence22,23,24. However, Zhang and colleagues also found that PCV-2 benefits from upregulating ROS for virus replication25,26,27,28. The increment of cellular ROS could induce the nuclear high mobility group box 1 protein (HMGB1) to translocate to the cytosol and enhance the PCV-2 replication in nuclear. The HMGB1 is a ubiquitously present DNA-binding protein that enhances the inflammatory response as a pro-inflammatory cytokine in virus-infected cells25,29,30. Some studies have shown that H2 negatively regulates HMGB1 function, effectively reducing cell inflammation and apoptosis31,32,33. Therefore, we speculate that AAS-enhanced PCV-2 production not only inhibits the ROS-induced cellular stress response but also negatively regulates HMGB1 to increase PCV-2 production. Furthermore, in Fig. 6, the PK-15 cells continued to grow and produced the virus antigen after 144 h.p.i (day 8). This phenomenon is similar to the virus-persistent cells that were observed in our previous study following BEFV infection in BHK-21 cells6. These persistent cells may be caused by cellular stress responses and cellular senescence-like responses, as a cellular antiviral mechanism.
Many studies suggest that molecular hydrogen is a novel and promising antioxidant. However, the limited solubility (approximately 0.00016 g/100 mL in water)34 is challenged for its antioxidant effectiveness. The AAS in the present study can stably regulate the flow rate and activation frequency, achieving a consistent supply of molecular hydrogen. This demonstrates that applying an antioxidant device in a bioreactor can provide a long-term, stable supply of H2, thereby achieving optimal antioxidant efficiency in the bioreactor system. Directly adding chemical reagents into the cell culture medium may be a convenient way to achieve antioxidant purposes. Nevertheless, using the AAS directly generates H2 into the culture media without chemical residual concern would be easier to employ by the GMP manufacturing process.
In the present study, the features of AAS employed in the bioreactor were checked, including (1) the AAS can continuously deliver H2 into the culture medium without exhibiting cytotoxicity; (2) the AAS can significantly reduce cellular ROS in the high-density bioreactor; (3) incorporate AAS with bioreactor can increase the BEFV and PCV-2 virus production. In conclusion, we described a novel strategy by using the AAS-connected bioreactor, which effectively alleviated the cellular oxidative stress in high-density cell culture and increased BEFV and PCV-2 production. Using the AAS can be employed by a GMP manufacturing process easily to improve production efficacy.
Material and methods
Cell lines, virus strains, and medium
Baby Hamster Kidney BHK-21 cell line (BHK-21) was purchased from the Institute of Bio-resource Collection and Research Center (BCRC), Hsinchu, Taiwan. Porcine Kidney-15 (PK-15) was a kindly gift from Dr. Chun-Yen Chu. Both cell lines were cultured in Eagles Minimum Essential Medium (MEM, Invitrogen, NY, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Mexico, USA) at 37 °C in an atmosphere of 5% CO2. The BEFV strain Tn8812835,36 and PCV-2 isolated in Taiwan were adapted in BHK-21 and PK-15 cells respectively. MEM supplemented with 2% FBS is employed for virus culture.
Lab-scale bioreactor BelloCell-500AP and the connection of antioxidative auxiliary system (AAS)
The BelloCell-500AP lab-scale bioreactor (Esco Bioengineer Co., Taichung, Taiwan) was used as the experimental platform in the present study. The antioxidant auxiliary system (AAS) includes a proton exchange membrane electrolyzer (PEM, NafionTM, DuPont, USA), a single-board microcontroller, two 3D printed peristaltic pumps, and the buffer supplementary. The BelloCell-500AP bioreactor perfusion circulation tube was connected to the cathode of the proton exchange membrane electrolyzer. This can generate H2 into cell culture media directly. At the same time, pure water was supplied to the anode. The AAS administered a constant current of 0.5 A and was programmed to activate at 15-minute intervals, followed by a 15-minute rest in periods. This precise regimen was employed to maintain a stable concentration of hydrogen molecules within the culture medium and didn’t change the pH of the BelloCell 500-AP bioreactor during the high-density cell culture period. BelloCell 500-AP stage settings are listed as the following: during cell attachment rising rate 2 mm/sec., top holding time 20 sec., down rate 2 mm/sec. and bottom holding time 0 sec.; during cell culture rising rate 1.5 mm/sec., top holding time 20 sec., down rate 1.5 mm/sec., bottom holding time 20 sec.; during virus infection rising rate of 2 mm/sec., top holding time 30 sec., down rate of 2 mm/sec., bottom holding time of 0 sec. The cell numbers were counted by CVD Nucleus Count Kit (Esco Bioengineer Co., Taichung, Taiwan). The H2 and pH of the cell culture media were determined by a Dissolved Hydrogen Meter-DH30 (DH30, Twinno, Taipei, Taiwan) and a LAQUAact pH-22 pH meter (HORIBA Advanced Techno, Co., Ltd., Kyoto, Japan) respectively. The hydrogen concentration will be controlled as 600 ppb-800 ppb upon this condition setting. The glucose concentrations were analysis by the GIucCeII® Glucose Monitoring System (Esco Bioengineer Co., Taichung, Taiwan). Glucose consumption was calculated as the difference between previous glucose concentration and post-glucose concentration according to the equation:
The measurement of ROS generation
The BioNOC II carrier strips were taken daily from the BelloCell-500AP and were treated with 0.05% trypsin at 10 min then suspended the cells in growth media. After treating the cells with the indicated concentration of H2O2 at 25 °C avoid light for one hour, the cell reactive oxygen species (ROS) was labeled by the Reactive Oxygen Species (ROS) Detection Assay Kit (ab287839, Abcam, Cambridge, UK) and followed by flow cytometry analysis. The labeling process followed the kit indication. Gently pipette cells up and down to ensure single-cell suspension and analyze on a flow cytometer (BD Accuri™ C6, BD Biosciences, USA). The ROS stain positive cells were showed as percentage within 10,000 cells.
Virus tittering
The virus samples were centrifuged at 2000 × g to separate cell debris. The BEFV amounts were determined by tissue culture infectious dose-50 method, calculated as the Reed and Muench method (1938) and expressed as TCID50/mL. The viruses were serially tenfold diluted and applied to wells containing 2 × 104 BHK-21 cells/well in 96-well micro-titration plates (Thermo Scientific Nunc, USA). The plates were incubated at 37 °C, 5% CO2 for three days then observed daily for cytopathic effect (CPE). The PCV-2 amounts were determined by qPCR method with a tittered virus sample standard each time and presented as TCID50/mL. The PCV-2 viral DNA was isolated by Viral Nucleic Acid Extraction Kit II (GeneAid, Taiwan). The qPCR reactions were performed using QuantiFast SYBR Green PCR Master Mix (Qiagen, Hilden, Germany). The amplification reactions were performed as follows: 95 °C for 3 min and 40 cycles of 95 °C for 15 s., 53.8 °C for 30 s., and 72 °C for 15 s. The primer pairs used for qPCR were PCV-2 detection-F: 5’-AACCACAGTCAGAACGCCC-3’ and PCV-2 detection-R: 5’-AGAAGGGCT GGGTAATGGTG-3’.
Statistical analysis
Experimental results represent the mean ± standard deviation (SD). The data were analyzed in R software with an agricolae package. The indicated statistical analysis was performed by two-tailed Student’s t-test, or two-way analysis of variance (ANOVA). Further multiple comparisons were analyzed by Tukey’s HSD tests. The significance was accepted at p < 0.05.
Data availability
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
References
Tapia, F., Vázquez-Ramírez, D., Genzel, Y. & Reichl, U. Bioreactors for high cell density and continuous multi-stage cultivations: Options for process intensification in cell culture-based viral vaccine production. Appl. Microbiol. Biotechnol. 100, 2121–2132 (2016).
Fang, Z. et al. Application of bioreactor technology for cell culture-based viral vaccine production: Present status and future prospects. Front. Bioeng. Biotechnol. 10, 921755 (2022).
Gallo-Ramírez, L. E., Nikolay, A., Genzel, Y. & Reichl, U. Bioreactor concepts for cell culture-based viral vaccine production. Expert Rev. Vaccines 14, 1181–1195 (2015).
Chevallier, V., Andersen, M. R. & Malphettes, L. Oxidative stress-alleviating strategies to improve recombinant protein production in CHO cells. Biotechnol. Bioeng. 117, 1172–1186 (2020).
Komuczki, D. et al. High cysteine concentrations in cell culture media lead to oxidative stress and reduced bioprocess performance of recombinant CHO cells. Biotechnol. J. 17, e22000029 (2022).
Zeng, Y. J. et al. A senescence-like cellular response inhibits bovine ephemeral fever virus proliferation. Vaccines (Basel) 9, 601 (2021).
Sies, H., Berndt, C. & Jones, D. P. Oxidative stress. Annu. Rev. Biochem. 86, 715–748 (2017).
Sies, H. On the history of oxidative stress: Concept and some aspects of current development. Curr. Opin. Toxicol. 7, 122–126 (2018).
Aranda-Rivera, A. K., Cruz-Gregorio, A., Arancibia-Hernández, Y. L., Hernández-Cruz, E. Y. & Pedraza-Chaverri, J. RONS and oxidative stress: An overview of basic concepts. Oxygen 2, 437–478 (2022).
Murphy, M. P. et al. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat. Metab. 4, 651–662 (2022).
Sharifi-Rad, M. et al. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Front. Physiol. 11, 694 (2020).
Khan, N. A. et al. Oxidative stress specifically inhibits replication of dengue virus. J. Gen. Virol. 102, 1–14 (2021).
Poljsak, B., Šuput, D. & Milisav, I. Achieving the balance between ROS and antioxidants: When to use the synthetic antioxidants. Oxid. Med. Cell. Longevity (2013).
Rahman, K. Studies on free radicals, antioxidants, and co-factors. Clin. Interv. Aging 2, 219–236 (2007).
Ohta, S. Molecular hydrogen is a novel antioxidant to efficiently reduce oxidative stress with potential for the improvement of mitochondrial diseases. Biochimica et Biophysica Acta Gen. Subj. 1820, 586–594 (2012).
Ohta, S. Recent progress toward hydrogen medicine: Potential of molecular hydrogen for preventive and therapeutic applications. Curr. Pharm. Des. 17, 2241–2252 (2011).
Asada, R., Tazawa, K., Sato, S. & Miwa, N. Effects of hydrogen-rich water prepared by alternating-current-electrolysis on antioxidant activity, DNA oxidative injuries, and diabetes-related markers. Med. Gas Res. 10, 114–121 (2020).
Xiao, L. & Miwa, N. Hydrogen-rich water achieves cytoprotection from oxidative stress injury in human gingival fibroblasts in culture or 3D-tissue equivalents, and wound-healing promotion, together with ROS-scavenging and relief from glutathione diminishment. Hum. Cell 30, 72–87 (2017).
Kato, S., Saitoh, Y., Iwai, K. & Miwa, N. Hydrogen-rich electrolyzed warm water represses wrinkle formation against UVA ray together with type-I collagen production and oxidative-stress diminishment in fibroblasts and cell-injury prevention in keratinocytes. J. Photochem. Photobiol. B 106, 24–33 (2012).
Tripathi, N. K. & Shrivastava, A. Recent developments in bioprocessing of recombinant proteins: Expression hosts and process development. Front. Bioeng. Biotechnol. 7, 00420 (2019).
Xu, W. J., Lin, Y., Mi, C. L., Pang, J. Y. & Wang, T. Y. Progress in fed-batch culture for recombinant protein production in CHO cells. Appl. Microbiol. Biotechnol. 107, 1063–1075 (2023).
Di Micco, R., Krizhanovsky, V., Baker, D. & d’Adda di Fagagna, F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 22, 75–95 (2021).
Baz-Martínez, M. et al. Cell senescence is an antiviral defense mechanism. Sci. Rep. 6, 37007 (2016).
Seoane, R., Vidal, S., Bouzaher, Y. H., El Motiam, A. & Rivas, C. The interaction of viruses with the cellular senescence response. Biology 9, 1–16 (2020).
Sun, R. et al. PCV2 induces reactive oxygen species to promote nucleocytoplasmic translocation of the viral DNA binding protein HMGB1 to enhance its replication. J. Virol. 94, e00238-e320 (2020).
Zhang, Y., Sun, R., Li, X. & Fang, W. Porcine circovirus 2 induction of ROS is responsible for mitophagy in PK-15 cells via activation of Drp1 phosphorylation. Viruses 12, 289 (2020).
Chen, X. et al. Interaction of porcine circovirus type 2 replication with intracellular redox status in vitro. Redox Rep. 18, 186–192 (2013).
Chen, X. et al. Reactive oxygen species regulate the replication of porcine circovirus type 2 via NF-κB pathway. Virology 426, 66–72 (2012).
Yang, H., Antoine, D. J., Andersson, U. & Tracey, K. J. The many faces of HMGB1: Molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J. Leukoc. Biol. 93, 865–873 (2013).
Liu, Y. et al. Protective effects of hydrogen enriched saline on liver ischemia reperfusion injury by reducing oxidative stress and HMGB1 release. BMC Gastroenterol. https://doi.org/10.1186/1471-230X-14-12 (2014).
Yu, Y. et al. Hydrogen gas reduces HMGB1 release in lung tissues of septic mice in an Nrf2/HO-1-dependent pathway. Int. Immunopharmacol. 69, 11–18 (2019).
Ding, X., Li, S. & Zhu, L. Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases. Cytokine Growth Factor Rev. 62, 54–61 (2021).
Tian, Y. et al. Hydrogen, a novel therapeutic molecule, regulates oxidative stress, inflammation, and apoptosis. Front. Physiol. https://doi.org/10.3389/fphys.2021.789507 (2021).
Huang, L. Molecular hydrogen: A therapeutic antioxidant and beyond. Med. Gas Res. 6, 219–222 (2016).
Cheng, L. T., Zeng, Y. J., Chu, C. Y. & Wang, H. Y. Development of a quick dot blot assay for the titering of bovine ephemeral fever virus. BMC Vet. Res. 15, 313 (2019).
Hsieh, Y.-C. et al. DNA sequence analysis of glycoprotein g gene of bovine ephemeral fever virus and development of a double oil emulsion vaccine against bovine ephemeral fever. Vet. Med. Sci. 68, 543–548 (2006).
Funding
This study was supported by a grant from the National Science and Technology Council (MOST 109-2313-B-020-005), Taiwan, R.O.C. The funding agency played no role in study design, data analysis, or manuscript writing.
Author information
Authors and Affiliations
Contributions
Y.J.Z. and H.Y.W. designed the study and performed the experiments. M.K.H. helps to analyze and calculate the data. J.R.C. performed the PCV-2 virus infection assay. Y.J.Z. and H.Y.W. wrote this paper. All authors have read and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zeng, YJ., Hsu, MK., Cai, JR. et al. A strategy of novel molecular hydrogen-producing antioxidative auxiliary system improves virus production in cell bioreactor. Sci Rep 14, 4092 (2024). https://doi.org/10.1038/s41598-024-54847-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-54847-7
Keywords
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.